Table 1 Baseline characteristics of participants according to quartiles of TyG index among postmenopausal women
Characteristic | Quartiles of TyG index | |||
|---|---|---|---|---|
Q1(< 8.26) | Q2(8.26–8.62) | Q3(8.62–9.07) | Q4(9.07–12.78) | |
Number of participants | 1995 | 1914 | 1911 | 1921 |
Age, years | 54.48 ± 6.01 | 55.24 ± 6.36 | 55.89 ± 6.29 | 56.40 ± 6.15 |
Age at menopause, years | 49.93 ± 3.43 | 50.17 ± 3.35 | 50.23 ± 3.49 | 50.44 ± 3.36 |
BMI, kg/m2 | 23.84 ± 3.40 | 24.87 ± 3.50 | 25.83 ± 3.44 | 26.36 ± 3.53 |
SBP, mmHg | 123.40 ± 18.34 | 128.50 ± 19.58 | 132.84 ± 20.43 | 135.63 ± 20.28 |
DBP, mmHg | 78.76 ± 10.12 | 81.03 ± 10.44 | 83.25 ± 10.76 | 84.15 ± 10.80 |
FBG mmol/L | 4.80 ± 0.72 | 5.10 ± 0.82 | 5.38 ± 1.05 | 6.61 ± 2.53 |
HDL-C, mmol/L | 1.74 ± 0.86 | 1.62 ± 0.99 | 1.56 ± 0.41 | 1.46 ± 0.46 |
TC, mmol/L | 4.92 ± 0.94 | 5.19 ± 0.95 | 5.48 ± 1.75 | 5.45 ± 1.39 |
LDL, mmol/L | 2.24 ± 1.15 | 2.49 ± 0.99 | 2.59 ± 1.07 | 2.53 ± 1.11 |
TG, mmol/L | 0.77(0.63, 0.90) | 1.16(1.03, 1.29) | 1.63(1.43, 1.85) | 2.65(2.16, 3.51) |
Hs-CRP, mg/L | 0.93(0.38, 2.90) | 1.10(0.42, 3.00) | 1.50(0.60, 3.50) | 1.90(0.80, 4.62) |
Tyg index | 7.94 ± 0.27 | 8.44 ± 0.10 | 8.83 ± 0.13 | 9.55 ± 0.45 |
Current drinker, n(%) | 97(4.86) | 79(4.13) | 80(4.19) | 74(3.85) |
Current smoker, n(%) | 26(1.30) | 37(1.93) | 31(1.62) | 47(2.45) |
Physical activity, n(%) | 372(18.65) | 351(18.34) | 352(18.42) | 379(19.73) |
Education status, n(%) | ||||
Illiterate | 8(0.40) | 9(0.47) | 7(0.37) | 8(0.42) |
Primary school | 120(6.02) | 116(6.06) | 133(6.96) | 169(8.80) |
Junior high school | 1346(67.47) | 1328(69.38) | 1284(67.19) | 1289(67.10) |
High school | 375(18.80) | 349(18.23) | 381(19.94) | 359(18.69) |
College degree or above | 146(7.32) | 112(5.85) | 106(5.55) | 96(5.00) |
Salt intake, n(%) | ||||
< 6 g/day | 279(13.98) | 262(13.69) | 269(14.08) | 247(12.86) |
6–12 g/day | 1607(80.55) | 1538(80.36) | 1488(77.86) | 1545(80.43) |
> 12 g/day | 109(5.46) | 114(5.96) | 154(8.06) | 129(6.72) |
Anti-diabetic drugs, n(%) | 14(0.70) | 32(1.67) | 64(3.35) | 185(9.63) |
Antihypertensive drugs, n(%) | 166(8.32) | 239(12.49) | 354(18.52) | 391(20.35) |
Lipid-lowering drugs, n(%) | 18(0.90) | 22(1.15) | 38(1.99) | 54(2.81) |